General introduction 41 1 Semkovska, M. et al. (2019) ‘Cognitive function following a major depressive episode: a systematic review and meta-analysis’, The Lancet Psychiatry. Elsevier Ltd, 6(10), pp. 851–861. doi: 10.1016/S22150366(19)30291-3. Sturdy, S. et al. (2020) ‘Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening’, Wellcome Open Research, 5. doi: 10.12688/wellcomeopenres.16057.2. Thissen, A. J. A. M. et al. (2010) ‘Bruikbaarheid en validiteit van de Nederlandse versie van de Montreal Cognitive Assessment (MoCA-D) bij het diagnosticeren van Mild Cognitive Impairment’, Tijdschrift voor Gerontologie en Geriatrie, 41(6), pp. 231–240. doi: 10.1007/s12439-010-0218-0. Visser, P. J. and Verhey, F. J. (2008) ‘Mild cognitive impairment as predictor for Alzheimer’s disease in clinical practice: Effect of age and diagnostic criteria’, Psychological Medicine, 38(1), pp. 113–122. doi: 10.1017/S0033291707000554. Volksgezondheidenzorg.info (2019) Dementia numbers and context. Available at: https://www. volksgezondheidenzorg.info/onderwerp/dementie/cijfers-context/huidige-situatie#node-aantalnieuwe-gevallen-naar-leeftijd (Accessed: 20 January 2020). Wilson, J. M. and Jungner, G. (1968) Principles and practices of screening for disease. PublicHealthPapers. Geneva: World Health Organisation. Available at: https://apps.who.int/iris/handle/10665/37650 (Accessed: 12 May 2022). Winblad, B. et al. (2004) ‘Mild cognitive impairment - Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment’, in Journal of Internal Medicine, pp. 240–246. doi: 10.1111/j.1365-2796.2004.01380.x. Zhao, Q. F. et al. (2016) ‘The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: Systematic review and meta-analysis’, Journal of Affective Disorders, 190, pp. 264–271. doi: 10.1016/j. jad.2015.09.069.
RkJQdWJsaXNoZXIy MTk4NDMw